Closing the Equity Gap: Trailblazing Initiative Holds Cancer Centers Accountable and Empowers Minority Women to Navigate and Advocate for Better Cancer Care
The Chrysalis Initiative Furthers CTTI's 'Transforming Trials 2030' Vision
SUMMARY
A
community activist motivated by personal experience formed The
Chrysalis Initiative in 2019 to disrupt
outcome disparities within breast cancer so all patients receive the care
they deserve, regardless of race. Its founder, who sits on CTTI's Steering
Committee, furthered CTTI's work by developing evidence-based strategies that
reshape the individual and institutional knowledge, attitudes, and behaviors
that impact health outcomes for Black women and other women of color (WOC) with
breast cancer.
GOAL(S)
When
it comes to Black women and cancer, the data tell a compelling and concerning story. Black
women are 40 percent more likely than the rest of the population to face
mortality from breast cancer, a phenomenon that is often attributed to social
determinants of health such as income or education levels or lack of health
insurance. But evidence doesn't back up this assumption. In fact, Black women
have a lower cancer incidence rate compared to White women, and racial
disparities are most
pronounced among
Black women of high socioeconomic status. Black women actually seek care and
diagnosis at a younger age than their White counterparts, and yet their care is
often delayed, incomplete, or otherwise substandard.
These findings force us to consider an uncomfortable truth: that the problem lies primarily with explicit and implicit (conscious and unconscious) bias in the healthcare system, resulting in a kind of structural racism in cancer care institutions – a challenge that isn't helped by the fact that only 2 percent of oncologists are Black. In a systemically inequitable healthcare system, Black women are often dismissed and ignored, and are treated with prejudices that keep them from receiving the proper standard of care. Led by its founder, The Chrysalis Initiative addresses these disparities with innovative interventions, in pursuit of the goal of ensuring all patients receive the care they deserve.
These findings force us to consider an uncomfortable truth: that the problem lies primarily with explicit and implicit (conscious and unconscious) bias in the healthcare system, resulting in a kind of structural racism in cancer care institutions – a challenge that isn't helped by the fact that only 2 percent of oncologists are Black. In a systemically inequitable healthcare system, Black women are often dismissed and ignored, and are treated with prejudices that keep them from receiving the proper standard of care. Led by its founder, The Chrysalis Initiative addresses these disparities with innovative interventions, in pursuit of the goal of ensuring all patients receive the care they deserve.
CHALLENGES
The
Chrysalis Initiative had a humble but determined start. It began with just one
individual, a 39-year-old Black mother of three who discovered that she had
stage 4 metastatic breast cancer. The
determination to overcome shock and to fight and survive for her family
launched her into vigorous exploration of what she was up against. In making
herself fully knowledgeable about her health challenge, she realized how many
questions other WOC had about their care. Many of these women also weren't
benefiting from a full set of options offered and were then falling short of
the self-advocacy they needed. It became clear to her that coaching and
navigation could overcome this problem. She needed a process to engage these
patients with mentoring, counseling, and resource direction that would equip
them with the tools to secure better care. She also needed to align with groups
similarly invested in equitable care who could help make her initiative an
influential, trusted force in cancer care.
SOLUTION(S)
The
vision for The Chrysalis Initiative could not thrive in a "business as usual" research environment, particularly with its special emphasis on directing WOC
to clinical trials. It depended on generating a new paradigm across multiple aspects
of the clinical research process, several of which CTTI has outlined in its Transforming Trials
2030
vision and its commitment to diversity
in trials.
Specifically, The Chrysalis Initiative sought to improve equity through
patient-centered, easily accessible research; deeper integration of research in
everyday health processes; and furthering research that contributes important
knowledge to all patient groups. With its focus on simplifying and
communicating criteria for recruitment and steps to enrollment, along with
matching its individual patients to trials per their clinical status, Chrysalis
was pursuing missing pieces to minority patient participation in research. Noting
the alignment of goals, CTTI reached out to The Chrysalis Initiative
for perspective on bringing diversity to clinical trials, sparking a fruitful
relationship for both parties.
TAKING ACTION
The
founder of The Chrysalis Initiative is advancing CTTI objectives with a program
that connects minority communities to resources that will improve their
knowledge and ensure standards-adherent care. Chrysalis approached the
challenge from several angles:
1) Patient support – Patient-centered cancer care requires support systems to address the unique needs of all patients. That's why The Chrysalis Initiative invites newly diagnosed patients to participate in one-on-one coaching to help them feel confident and in charge of their cancer journey. Coaching addresses challenges specific to WOC with cancer that are often not understood or that are overlooked entirely by cancer providers. For example, side effects of cancer treatments manifest differently in Black women than in other races and hair loss from chemotherapy often carries a unique emotional burden in these groups. WOC are also less likely to be offered genetic testing. To further close these gaps, patients are invited to use the BC NAVI app, a mobile-phone and desktop platform that provides educational support to patients with breast cancer through training modules, webinars, videos, events, links to helpful websites, and more. The app helps to track patient progress and gather data on problems and successes.
2) Connecting patients with relevant trials – Black patients account for just 5 percent of clinical trial participants in the United States, while African Americans account for more than 12 percent of the country's general population. This disproportion leaves blind spots in research results and drives potential distrust of the resulting healthcare among these communities. Ensuring research contributes knowledge to the full diversity of patient groups means bringing more Black and other disparate groups into the research fold. Although the traditional narrative is that Black participants inherently distrust research, opportunities to participate are also not presented equitably to Black and other underrepresented patients.
The Chrysalis Initiative counters this by serving as a trusted voice to meaningfully connect research opportunities with patients who may benefit. It is not about simply steering Black patients to trials to increase diversity generally, but rather investing time to ensure matches are specific to the patient's cancer profile and history, thus increasing the odds of treatment success. The organization also focuses on communicating the tremendous opportunity research can offer Black and other disparate groups of patients. "Research participation shouldn’t be considered a last resort, but rather as a VIP opportunity to access innovative therapies that are not yet on market," said Chrysalis' founder. "When Black women participate in research, we not only unlock potential opportunities for success in our own treatment but also for millions of other Black women seeking insights on new treatments who need to see themselves reflected in the research. We deserve to be represented."
3) Accountability at cancer care centers – To better integrate research into the everyday health processes of Black and other underserved cancer communities, cancer care centers must acknowledge the need for change. The Chrysalis Initiative founder stresses that most cancer centers are well intentioned, but simply aren’t aware of the bias that creeps into their practices. So how can providers ensure their cancer care delivery system is equitable, not only by intention, but in demonstrated impact? To answer this challenge, the Initiative designed an Equity Assessment, Tools and Improvement Plan, which provides an evidence-based system-wide audit that brings about intervention and training for cancer centers and other organizations. When Chrysalis reports on how a care group performed in its assessment, it uses indisputable data to illustrate inequity. For example, the report may note significantly higher percentages of White women being referred for additional radiologic imaging than Black women with a similar clinical profile. Through post-assessment training and discussion, the process probes these kinds of disparities and invites the organization to consider its practices, working collaboratively and cooperatively with provider and administrative staff.
"Most organizations are surprised at the results of the assessment, but welcome our advice for how to improve," said Chrysalis' founder. "Once persistent patterns of treatment and diagnosis are highlighted in no uncertain terms and with data, they are often grateful for the knowledge and eager to hear our guidance on how to remedy any inequity."
1) Patient support – Patient-centered cancer care requires support systems to address the unique needs of all patients. That's why The Chrysalis Initiative invites newly diagnosed patients to participate in one-on-one coaching to help them feel confident and in charge of their cancer journey. Coaching addresses challenges specific to WOC with cancer that are often not understood or that are overlooked entirely by cancer providers. For example, side effects of cancer treatments manifest differently in Black women than in other races and hair loss from chemotherapy often carries a unique emotional burden in these groups. WOC are also less likely to be offered genetic testing. To further close these gaps, patients are invited to use the BC NAVI app, a mobile-phone and desktop platform that provides educational support to patients with breast cancer through training modules, webinars, videos, events, links to helpful websites, and more. The app helps to track patient progress and gather data on problems and successes.
2) Connecting patients with relevant trials – Black patients account for just 5 percent of clinical trial participants in the United States, while African Americans account for more than 12 percent of the country's general population. This disproportion leaves blind spots in research results and drives potential distrust of the resulting healthcare among these communities. Ensuring research contributes knowledge to the full diversity of patient groups means bringing more Black and other disparate groups into the research fold. Although the traditional narrative is that Black participants inherently distrust research, opportunities to participate are also not presented equitably to Black and other underrepresented patients.
The Chrysalis Initiative counters this by serving as a trusted voice to meaningfully connect research opportunities with patients who may benefit. It is not about simply steering Black patients to trials to increase diversity generally, but rather investing time to ensure matches are specific to the patient's cancer profile and history, thus increasing the odds of treatment success. The organization also focuses on communicating the tremendous opportunity research can offer Black and other disparate groups of patients. "Research participation shouldn’t be considered a last resort, but rather as a VIP opportunity to access innovative therapies that are not yet on market," said Chrysalis' founder. "When Black women participate in research, we not only unlock potential opportunities for success in our own treatment but also for millions of other Black women seeking insights on new treatments who need to see themselves reflected in the research. We deserve to be represented."
3) Accountability at cancer care centers – To better integrate research into the everyday health processes of Black and other underserved cancer communities, cancer care centers must acknowledge the need for change. The Chrysalis Initiative founder stresses that most cancer centers are well intentioned, but simply aren’t aware of the bias that creeps into their practices. So how can providers ensure their cancer care delivery system is equitable, not only by intention, but in demonstrated impact? To answer this challenge, the Initiative designed an Equity Assessment, Tools and Improvement Plan, which provides an evidence-based system-wide audit that brings about intervention and training for cancer centers and other organizations. When Chrysalis reports on how a care group performed in its assessment, it uses indisputable data to illustrate inequity. For example, the report may note significantly higher percentages of White women being referred for additional radiologic imaging than Black women with a similar clinical profile. Through post-assessment training and discussion, the process probes these kinds of disparities and invites the organization to consider its practices, working collaboratively and cooperatively with provider and administrative staff.
"Most organizations are surprised at the results of the assessment, but welcome our advice for how to improve," said Chrysalis' founder. "Once persistent patterns of treatment and diagnosis are highlighted in no uncertain terms and with data, they are often grateful for the knowledge and eager to hear our guidance on how to remedy any inequity."
IMPACT
Three
years later, The Chrysalis Initiative has blossomed into a highly respected
nonprofit with 20 equity associates and 180 coaches. Its founder has testified
to the FDA in order to connect more women with resources for screenings,
treatment, and support. She has been featured in People Magazine,
the Philadelphia Inquirer, the Philadelphia Tribune; participated
in national campaigns for Anthropologie, Novartis, Pfizer and Cancer and
Careers; and was invited to speak as a guest on CBS News and Good
Morning America. The Initiative's Equity Assessment Tool has been
deployed in more than a dozen hospital/health systems and demand is growing
from more organizations.
ADVICE
The founder of The Chrysalis
Initiative is thrilled with how her nonprofit has developed, but knows there is
still a great distance to travel toward equitable care. Given that 100 percent
of participating hospital systems that took the Equity Assessment so far have found
areas for improvement, she believes the tool should be standard for health
systems in America.
"We are at an important turning point for health equity today, where there is finally an open acknowledgement of the systemic bias that pervades our healthcare interactions and a willingness to change," she said. "The interest and support is exploding, and we want to put it into action to fully meet this moment — and thereby make evidence-based accountability for equitable care and research part of the healthcare mainstream."
"We are at an important turning point for health equity today, where there is finally an open acknowledgement of the systemic bias that pervades our healthcare interactions and a willingness to change," she said. "The interest and support is exploding, and we want to put it into action to fully meet this moment — and thereby make evidence-based accountability for equitable care and research part of the healthcare mainstream."
ORGANIZATION
The Chrysalis Initiative
ORGANIZATION TYPE
Patient
IMPLEMENTATION DATE
2019
TOPIC
Clinical Trials Transformation